- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/495 - Transforming growth factor [TGF]
Patent holdings for IPC class C07K 14/495
Total number of patents in this class: 593
10-year publication summary
|
38
|
29
|
35
|
53
|
43
|
55
|
60
|
53
|
46
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 360 |
23 |
| Cue Biopharma, Inc. | 186 |
18 |
| The Johns Hopkins University | 5679 |
14 |
| NGM Biopharmaceuticals, Inc. | 178 |
14 |
| Biocon Limited | 219 |
13 |
| The Regents of the University of California | 19989 |
12 |
| Amgen Inc. | 4081 |
12 |
| Scholar Rock, Inc. | 117 |
11 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3171 |
11 |
| Modernatx, Inc. | 1259 |
9 |
| Merck Patent GmbH | 5812 |
8 |
| National Research Council of Canada | 1546 |
8 |
| In3bio Ltd. | 23 |
8 |
| Mayo Foundation for Medical Education and Research | 3225 |
6 |
| Genzyme Corporation | 1267 |
6 |
| Immatics Biotechnologies GmbH | 1156 |
6 |
| io Biotech ApS | 70 |
6 |
| President and Fellows of Harvard College | 5993 |
5 |
| Rutgers, The State University of New Jersey | 1896 |
5 |
| Notogen, Inc. | 5 |
5 |
| Other owners | 393 |